MEK and PI3K single agent treatment resulted in a tumor growth inhibition (area under the curve) of 44.6% and 24.4% respectively while the combination treatment resulted in ~60% tumor growth inhibition (Fig 5A). This evidence concerns the gene MAP2K7 and neoplasm.